Multiplex PCR pathogen reagent cprr
Ended Awarded Last action
- Contract number
- 36C25223N0647
- Awardee
-
Biofire Diagnostics LLC UEI TBBNREFT3LD3
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $612,896
Award facts
- Contract value 100% obligated
- $612,895.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Emigration Canyon, UT 84108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$1,302 | |
| Original award | $614,198 |
About this award
Biofire Diagnostics LLC received a $612,895.93 firm fixed-price blanket purchase agreement (BPA) call from the Department of Veterans Affairs' Veterans Integrated Service Network 12 on September 28, 2023, for multiplex PCR pathogen reagent (CPRR) products. The contract extends through November 20, 2025, and is performed at the contractor's facility in Emigration Canyon, Utah. This award was issued without a set-aside designation and falls under the company's existing GSA Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests (FSS-65-VII). Multiplex PCR reagents enable rapid simultaneous detection of multiple infectious disease pathogens from clinical samples, supporting the VA's diagnostic testing capabilities across its healthcare network.
Biofire Diagnostics is a Salt Lake City-based biotechnology company specializing in advanced molecular diagnostic systems, particularly FilmArray platforms designed for syndromic infectious disease detection. The company maintains a strong federal contract portfolio with the VA and other healthcare agencies, including multiple blanket purchase agreements and indefinite delivery vehicles valued between $329,552 and $4.83 million. Biofire's federal contracting strategy emphasizes firm fixed-price delivery orders and BPA calls that allow agencies to procure diagnostic products and maintenance services on an as-needed basis, supporting critical healthcare diagnostic capabilities across federal healthcare systems nationwide.
Quick answers
Who was awarded contract 36C25223N0647?
36C25223N0647 was awarded to Biofire Diagnostics LLC by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 28, 2023.
How much is contract 36C25223N0647 worth?
The government has obligated $612,896 on 36C25223N0647.
Is contract 36C25223N0647 an order under another contract?
Yes. 36C25223N0647 is a BPA call under V797D30085-36C25219A0002, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25223N0647 competed?
The extent of competition for 36C25223N0647 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award